Symposia Recordings

In effort to bring valuable information and education to a wider audience, the IPC develops webcasts of the symposia taking place at important congresses throughout the year that can be accessed at any time. 

---

Research on SARS-CoV-2 during the COVID-19 pandemic crisis: An IPC tribute to young researchers

2021 ESDR Virtual

 

• Autoantibodies to type I IFNs in patient with life-threatening COVID-19 | Paul Bastard, MD | France
  
• B-cell responses to SARS-CoV-2 in the setting of COVID-19 infection & vaccination | Zijun Wang, PhD | United States
  
• COVID-19 and psoriasis: Lessons from real-life registries | Satveer Mahil, PhD | United Kingdom
  
• Interactions between skin inflammatory diseases & COVID: Lessons from genomic epidemiology studies| Matthew Patrick, MEng, PhD | United States

---

The International Psoriasis Council update on the latest research

2021 IFPA Virtual

 

• IPC’s disease severity classification: What it means in the clinic | Lone Skov, MD, PhD | Denmark
  
• The future of teledermatology | Alexander Navarini, MD, PhD | Switzerland
  
• Psoriasis and diet | Jo Lambert, MD, PhD | Belgium
  
• Q & A and closing comments | All faculty

---

Challenging cases in psoriasis: A focus on COVID-19, biologics and adverse events

2021 RADLA Virtual

 

• COVID-19 and psoriasis | Peter van de Kerkhof, MD, PhD | Netherlands
  
• Challenging Case: Linfoma después del tratamiento biológico: ¿Qué fue primero? | Angela Londoño, MD | Colombia
  
• Challenging Case: Paradoxical psoriasis induced by anti-TNF | Romina Contreras, MD | Paraguay
• Challenging Case: To be or not to be? It is not always psoriasis. | Fernando Valenzuela, MD | Chile
  
• Challenging Case: Eventos adversos cutáneos durante la terapia biológica. | André Vicente Esteves de Carvalho, MD, PhD | Brazil
• Faculty Discussion | All faculty

---

Hot topics and challenging cases in psoriasis: A focus on COVID-19 and systemic/biologic treatment

2020 EADV Virtual

 

• An elderly patient with severe psoriasis - which treatment to consider | Peter van de Kerkhof, MD, PhD | Netherlands
  
• Challenging case: How to switch to the most optimal treatment | Craig Leonardi, MD | USA
  
• Challenging case: Patient at risk for developing severe case COVID-19 | Lluis Puig, MD, PhD | Spain
• Choosing the most appropriate first line biologic | Richard Warren, BSc, MBChB, FRCP, PhD | UK
  
• How to select a systemic treatment for your patient | Craig Leonardi, MD | USA

---

JSPR-IPC Joint Symposium: Personalized medicine in Psoriasis

2020 JSPR Virtual

 

• The concept of personalized medicine in the treatment of psoriasis | Peter van de Kerkhof, MD, PhD | Netherlands

---

Search ALl videos